Chad Therapeutics Quote - CTU | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
AMEX
Chad Therapeutics, (CTU) Share Price

Chad Therapeutics, (CTU)

0.00

0.00

( 0.00% )

Updated: -

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

-

Bid

-

Ask

-

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

-

Open

-

Last Trade

Last Trade Time

-

Average Volume (3m)

-

Financial Volume

-

VWAP

-

CHAD Therapeutics Plans to Begin Trading on the OTC Bulletin Board

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it plans to withdraw its common stock from the American Stock Exchange effective on August 29, 2008 because the Company...

Dormio Tech Division of CHAD Therapeutics Receives FDA Clearance to Market Its FloCHANNEL Sleep Diagnostic Device

Dormio Tech, a division of CHAD Therapeutics, Inc. (AMEX:CTU), announced today that it received 510(K) clearance from the FDA to market the Company's proprietary FloCHANNEL?...

CHAD Therapeutics Receives Letter From The American Stock Exchange Citing Non-Compliance With Certain Listing Requirements

CHAD Therapeutics, Inc. (AMEX:CTU) today announced that on July 23, 2008, it received a letter from the American Stock Exchange ("AMEX") stating that the Company was not in...

CHAD Therapeutics Reports Going Concern Qualification

CHAD Therapeutics, Inc. (AMEX:CTU) today reported that its independent registered accountants, Rose, Snyder & Jacobs, had qualified their opinion on the Company's March 31...

CHAD Therapeutics Closes Sale of Transfilling Assets for $1.825 Million in Cash

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has closed the sale of the assets related to its transfilling oxygen business for $1.825 million in cash, pursuant to...

CHAD Therapeutics Closes Sale of Its Oxygen Business to INOVO

CHAD Therapeutics, Inc. (AMEX:CTU) announced that it has closed the sale of the assets related to CHAD's oxygen conserving business to Inovo, Inc., a privately held manufacturer...

CHAD Therapeutics Reports Third Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today announced operating results for the third quarter and first nine months of fiscal 2008. "As previously announced, CHAD has decided to...

CHAD Therapeutics Shareholders Approve Sale of Company's Oxygen Business to INOVO

Following a special meeting of shareholders held today, CHAD Therapeutics, Inc. (AMEX:CTU) announced that its shareholders have approved the proposed sale for approximately...

CHAD Therapeutics Announces Mailing of Definitive Proxy Regarding Proposed Sale of Its Oxygen Business

CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has commenced mailing its definitive proxy statement to shareholders for approval of its proposed sale of assets...

CHAD Therapeutics Reports Fiscal 2008 First Quarter Results

CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008. First Quarter Results For the three months ended June 30, 2007...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CTU - Frequently Asked Questions (FAQ)

What is the current Chad Therapeutics share price?

The current share price of Chad Therapeutics is US$ 0.00

What is the 1 year trading range for Chad Therapeutics share price?

Chad Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TOVXTheriva Biologics Inc	US$ 1.7837 (37.21%)	6.56M
CTMCastellum Inc	US$ 0.576 (34.30%)	9.58M
GRFXGraphex Group Limited	US$ 0.272801 (33.73%)	2.19M
EXODExodus Movement Inc	US$ 43.20 (23.25%)	13.55k
KULRKULR Technology Group Inc	US$ 3.45 (21.91%)	39.37M
ZDGEZedge Inc	US$ 2.66 (-15.56%)	337.51k
AAPXT Rex 2X Long Apple Daily Target ETF	US$ 34.25 (-15.29%)	58.68k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 18.975 (-15.14%)	8.48M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 1.98 (-14.47%)	37.75M
SEAUS Global Sea to Sky Cargo ETF	US$ 13.00 (-14.02%)	6.05k
KULRKULR Technology Group Inc	US$ 3.45 (21.91%)	39.37M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 1.98 (-14.47%)	37.75M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 30.225 (2.15%)	35.66M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 5.82 (-2.84%)	33.48M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 11.89 (14.77%)	29.96M

pos_stock_hoarder

pos_stock_hoarder 2 minutes ago

I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d

crazy horse 0

crazy horse 0 2 minutes ago

Trump vows to direct DOJ to pursue death penalty in wake of Biden clemencies

“As soon as I am inaugurated, I will direct the Justice Department to vigorously pursue the death penalty to protect American families and children from violent rapists, murderers, and monsters,” Trump said

resx18

resx18 2 minutes ago

Great green close! $AURI

GREGG THE GREEK

GREGG THE GREEK 2 minutes ago

100% Rig

Same to you and all who contribute here.

Wishing you all the best !!!

Iceman

Iceman 2 minutes ago

All Time high closing price today, $44.58.

Merry Christmas!

Ice

pos_stock_hoarder

pos_stock_hoarder 3 minutes ago

I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d

88TH MAN

88TH MAN 3 minutes ago

FBEC Last Price: $0.0005 +0.0005 (+49,900.00%).

i_like_bb_stock

i_like_bb_stock 3 minutes ago

tw0122

tw0122 3 minutes ago

Nice W on bottom monthly and .68 break again eventually

GREGG THE GREEK

GREGG THE GREEK 3 minutes ago

Shaping up nicely for the bigger move.

RVPH

Mark

Mark 4 minutes ago

Yea, still waiting on it

glenn1919

glenn1919 4 minutes ago

CISO.......................https://stockcharts.com/h-sc/ui?s=CISO&p=W&b=5&g=0&id=p86431144783

stock1ace1

stock1ace1 4 minutes ago

NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its Board of Directors has formed an independent Special Committee to explo

pos_stock_hoarder

pos_stock_hoarder 4 minutes ago

I can't tell either!

https://assets.amuniversal.com/21ac52a0a41c013d8512005056a9545d

Ecomike

Ecomike 4 minutes ago

Merry Christmas MrKirby

stock1ace1

stock1ace1 4 minutes ago

NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its Board of Directors has formed an independent Special Committee to explo

al44

al44 4 minutes ago

Pssst, hey Nancy-

https://media.gettr.com/group7/getter/2024/12/24/17/d30f2d6b-b770-dcb6-3748-f9ab00f85e2e/a25c6971ac0e51f53198282fe0711573_768x0.png

Mark

Mark 5 minutes ago

trunkmonk

trunkmonk 5 minutes ago

Pretty much end of year stuff, taking losses or gains, switching between GSEs to avoid cap gains tax.

stock1ace1

stock1ace1 5 minutes ago

SNPX 1 Mill Float $19.6Mill cash on balance sheet = $15 Cash Per share !!

al44

al44 6 minutes ago

'Ok, Who Got Me The MAGA Hat?' Asks Kamala Harris As Jill Biden Stifles Laughter

https://media.babylonbee.com/articles/676ae98d72b3a676ae98d72b3b.jpg

WASHINGTON, D.C. — The traditional unwrapping of presents at the White House took an awkward turn this morning when Jill

ProfitChaser

ProfitChaser 6 minutes ago

Merry Christmas to you also and everyone. All I want Santa to bring me is a RV. LOL.

Lime Time

Lime Time 6 minutes ago

Santa run in the making 🚀

nelson1234

nelson1234 6 minutes ago

Merry Xmas Xroad boyz and galz!

Ecomike

Ecomike 6 minutes ago

Happy holidays to you too and all the IFUS Long Knives here. The only ones that are not fooled by basher tard lies they are paid by hedge funds in trouble, to post.

Chad Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions